Marnus Labuschagne Ruled Out of Entire New Zealand Test Series

The speculation is over. Australia’s chair of selectors George Bailey has confirmed that Marnus Labuschagne will not be considered for any of the four home Tests against New Zealand. The announcement lands just days before the squad for the opener in Perth is named, and it shakes up the top order.

Bailey Draws a Line Under the Speculation

Bailey spoke on Monday, November 9, ahead of the fourth round of the Sheffield Shield, which starts on Wednesday, November 12. He wanted to settle the uncertainty over Labuschagne’s place before that round began.

“We won’t be considering Marn for selection certainly for that first Test, but [also] for the New Zealand series. And the reason I just wanted to clear that up today is I think there’s going to be or has been a lot of speculation around his place in the team,” Bailey said, as quoted by Cricinfo.

The message is blunt. The door is closed for the whole home summer against the Kiwis, not just the first Test in Perth.

The Numbers Behind the Decision

Labuschagne was once ranked the world’s top Test batter. His recent returns tell a very different story.

His last Test hundred came in 2023 against England at Old Trafford. Since then the big scores have dried up at the highest level.

A Familiar Cycle

This is the second time in 17 months that Labuschagne has been left out of the Test squad. After the first omission in 2025, he hit back with five centuries in ten domestic innings for Queensland across two formats. That earned him a recall for the Ashes.

The runs, however, did not follow him back onto the Test stage.

Why Shield Runs May Not Be Enough

Bailey was open about the problem. Labuschagne has always been a big performer in first-class cricket, but that output did not carry over last time. The selectors admit it would be hard to recall him on domestic form alone.

“He’s always been an incredible performer at first-class level. So I expect that that’ll be the case [again]. So yeah, there’s no message to go back and do anything in particular,” Bailey said.

The plan is simple: go back to Queensland and focus on playing as well as he can for a period of time.

Is There a Way Back?

Bailey indicated Labuschagne could still work his way into contention for the tours of India and England in 2027. No guarantee was offered. He also played down the idea of a head-to-head shootout.

“But I don’t like the idea of a bat-off or a bowl-off in a one-off game, so I don’t think it’ll necessarily move the dial an enormous amount, but it certainly still has the potential to,” he said.

Who Is Pushing for the New Zealand Squad?

Selectors are close to finalising a 14-man squad, and the fourth round of the Shield is a final chance to make an impression. Bailey said there are still some great opportunities for players coming through.

Steven Smith is expected to be available for the opening Test, provided he gets medical clearance after the neck injury that cut short his South Africa tour. Travis Head has been given a break from the ODI series against England and will not play in the Shield round before the New Zealand series. Matt Renshaw is set to feature in round four.

Shield Availability at a Glance

• Sitting out the next two rounds: Pat Cummins, Mitchell Starc and Josh Hazlewood.
• Available for round four: Nathan Lyon, with Beau Webster, Matt Kuhnemann and Michael Neser also in contention.
• Set to play in round five: Josh Inglis, Cameron Green, Cooper Connolly, Alex Carey and Steven Smith.
• Confirmed for round five: Scott Boland.

The selectors will weigh all of these performances before naming the final 14 for the Perth opener.

What It Means for Australia’s Top Order

Labuschagne’s exclusion opens up the number three debate. Bailey’s stance shows the selectors are looking ahead rather than leaning on past reputation. For Labuschagne, the focus now turns to rebuilding at Queensland and chasing the 2027 tours.

For the rest of the squad, the message is clear. Every Shield innings counts before the New Zealand series begins.